Home | Welcome to Contract Pharma   
Last Updated Monday, May 20 2013
Print RSS Feed

Breaking News

Related Searches: Promotions & Moves •
MedImmune

November 6, 2007
MedImmune, Inc. has made several new senior appointments across the organization. Alexander A. Zukiwski, M.D., senior vice president, clinical research; Timothy J. Hahn, Ph.D., vice president, antibody manufacturing; and Timothy J. Maines, vice presi…  Read More »
DSM Expands Service Offerings

November 6, 2007
DSM Pharmaceuticals Inc. has expanded its service offerings to include formulation development and clinical trial manufacturing for solid dosage form products. “This expansion of services will have significant value-added benefits to our…  Read More »
Bilcare Completes Phase I of Expansion Program

November 5, 2007
Bilcare Global Clinical Supplies opened five state-of-the-art primary packaging rooms at its Phoenixville, PA facility as part of the company's expansion and modernization program. During 4Q2007 the company will complete the next phase of upgrades wi…  Read More »
Daiichi Sankyo, Lilly to Conduct Phase III Study Against Plavix

November 5, 2007
Daiichi Sankyo Co., Ltd. and Eli Lilly plan to begin a large Phase III trial in 2Q2008 to compare prasugrel, an investigational oral antiplatelet agent, against Bristol-Myers Squibb's clopidogrel (Plavix/Iscover) in medically managed patients with ac…  Read More »
SGS Gets European Outsourcing Award

November 5, 2007
SGS received the 2007 European Outsourcing Award for Best Contract Analytical Project. The award was sponsored by Via Media, Ltd., a UK-based company that sponsors ten award categories ranging from Best New Product to Best Merger/Acquisition. The awa…  Read More »
Charles River Laboratories

November 2, 2007
Charles River Laboratories International, Inc. has made several appointments. Brian Bathgate, Ph.D. has been named corporate senior vice president and president, European Preclinical Services. Jorg Geller, D.V.M., Ph.D. has been named corporate senio…  Read More »
FDA inspects Hovione TTC in NJ

November 2, 2007
Hovione's Technology Transfer Center (TTC) in New Jersey has passed successfully a pre-approval inspection by FDA. The three-day inspection was carried out by Ms. Joy R. Kozlowski-Klena, a compliance officer at FDA's Center for Drug Evaluation and Re…  Read More »
Laureate To Manufacture for ImmunoGen

November 2, 2007
Laureate Pharma, Inc. has entered into a contract manufacturing agreement with ImmunoGen, Inc. to manufacture the huC242 antibody used in production of ImmunoGen's huC242-DM4 Tumor-Activated Prodrug (TAP) compound, now in Phase II clinical testing. T…  Read More »
AstraZeneca 3Q

November 1, 2007
AstraZeneca 3Q Revenues: $7.2 billion (+10%, +6% at Constant Exchange Rates) 3Q Earnings: $1.4 billion (-15%) YTD Revenues: $21.4 billion (+11%, +7% CER) YTD Earnings: $4.4 billion (-6%) Comments: In a deliberately obfuscatory earnings…  Read More »
Millennium Pharma 3Q

November 1, 2007
Millennium Pharmaceuticals 3Q Revenues: $122 million (+18%) 3Q Loss: $1.7 million (loss of $13.7 million in 3Q06) YTD Revenues: $346 million (flat) YTD Loss: $26.2 million (loss of $52.2 million in YTD06) Comments: U.S. net sales of Ve…  Read More »
Draxis Health

November 1, 2007
Dr. Martin Barkin will retire as president and chief executive officer of Draxis Health at the end of the year. Dr. Barkin joined the senior management of Draxis in 1992. Dan Brazier, presently chief operating officer, will immediately take on the ro…  Read More »
MedImmune Exercises Target Option with Seattle Genetics

October 31, 2007
MedImmune has exercised an option to obtain an exclusive license to an antigen target under its antibody-drug conjugate (ADC) collaboration with Seattle Genetics, triggering a $1.5 million payment. This is the second target MedImmune has licensed thr…  Read More »
Emisphere To Move HQ

October 31, 2007
Emisphere Technologies, Inc. will move its corporate headquarters from Tarrytown, NY to Cedar Knolls, NJ. Emisphere will retain its scientific staff and laboratory facilities in Tarrytown. "This move allows us to better serve all of our cust…  Read More »
Kendle 3Q

October 31, 2007
Kendle International 3Q Revenues: $142 million (+47%) 3Q Earnings: $3.7 million (-5%) YTD Revenues: $414 million (+62%) YTD Earnings: $12.3 million (-6%) Comments: Net service revenues grew 33% in 3Q07 to $100 million, and 49% YTD to $…  Read More »
Lilly Licenses Pain Drug from Glenmark

October 30, 2007
Lilly has entered into an agreement with Glenmark Pharmaceuticals S.A., a wholly owned subsidiary of Glenmark Pharmaceuticals Limited India, to acquire the rights to a portfolio of transient receptor potential vanilloid sub-family 1 (TRPV1) antagonis…  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: